| (USD) | Dec 2016 | Y/Y change |
|---|---|---|
| Revenue | 71.00K | — |
| Operating expense | — | — |
| Net income | -30.71M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NWBO returned -31.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -25.1% |
| 1 year | -31.1% |
| 5 years | -86.9% |
| 10 years | -49.4% |
| All-time high | $1,200.00 (Dec 2001) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in NWBO would be worth today ›No. Northwest Biotherapeutics, Inc. has not paid a dividend in the past 12 months.
Northwest Biotherapeutics, Inc. is part of the Healthcare sector.
Northwest Biotherapeutics, Inc. has a market cap of 293.71M USD, based on the latest quote.
Northwest Biotherapeutics, Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
